Turmeric ( DrugBank: Turmeric )

4 diseases

ID	Disease name (Link within this page)	Number of trials
140	Dorabe syndrome	1
144	Lennox-Gastaut syndrome	1
158	Tuberous sclerosis	1
299	Cystic fibrosis	1

140. Dorabe syndrome

Clinical trials : 116 / Drugs : 65 - (DrugBank : 17) / Drug target genes : 50 - Drug target pathways : 64

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

Clinical trials : 111 / Drugs : 72 - (DrugBank : 14) / Drug target genes : 49 - Drug target pathways : 61

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

Clinical trials : 112 / Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00219882 (ClinicalTrials.gov)	April 2005	16/9/2005	Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis	A Phase I Safety and Dose Finding Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis Who Are Homozygous for Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (?F508 CFTR) Mutation	Cystic Fibrosis	Drug: standardized turmeric root extract	Ramsey, Bonnie, MD	Seer Pharmaceuticals;CF Therapeutics Development Network Coordinating Center;Cystic Fibrosis Foundation Therapeutics	Completed	18 Years	40 Years	Both	11	Phase 1	United States